Showing results (281-290 of 425) with videos related to

Sort By:
Pageof 43
Brain : a Journal of Neurology|August 12, 2025
Design considerations for C9orf72 disease prevention trialsMichael Benatar, Adam M Staffaroni, Joanne Wuu, et al.
Neurology|November 17, 2020
Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer DiseaseIgnacio Illán-Gala, Alberto Lleo, Anna Karydas, et al.
Brain : a Journal of Neurology|January 31, 2019
Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trialsAdam M Staffaroni, Peter A Ljubenkov, John Kornak, et al.
Neurobiology of Aging|January 11, 2020
Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI studyQin Chen, Bradley F Boeve, Matthew Senjem, et al.
Molecular Neurodegeneration|August 10, 2018
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseasesJason A Chen, Zhongbo Chen, Hyejung Won, et al.
Neurology|February 18, 2018
Early vs late age at onset frontotemporal dementia and frontotemporal lobar degenerationSang Won Seo, Marie-Pierre Thibodeau, David C Perry, et al.
Brain : a Journal of Neurology|October 3, 2014
Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansionSuzee E Lee, Anna M Khazenzon, Andrew J Trujillo, et al.
Neurology|October 16, 2016
Progression of brain atrophy in PSP and CBS over 6 months and 1 yearShubir Dutt, Richard J Binney, Hilary W Heuer, et al.
Nature Medicine|November 24, 2022
CSF tau microtubule-binding region identifies pathological changes in primary tauopathiesKanta Horie, Nicolas R Barthélemy, Salvatore Spina, et al.
The Lancet. Neurology|May 25, 2019
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trialAdam L Boxer, Irfan Qureshi, Michael Ahlijanian, et al.
Pageof 43